The cost-effectiveness on sedative medication and regular medication
Comprehensive review
Keywords:
sedative medication, cost-effectiveness, regular medicationAbstract
When it comes to managing various medical conditions, the choice of medication can have a significant impact on both the patient's well-being and the overall healthcare costs. Two broad categories of medications that are widely used are sedation-controlled medications and regular medications. Sedation-controlled medications are designed to provide a level of sedation or drowsiness, often used for conditions such as insomnia, anxiety, or pain management. Regular medications, on the other hand, are not primarily focused on inducing sedation and are used to treat a wide range of medical issues. The goal of this study is to identify the most cost-effective sedation-controlled or regular medication, taking into account factors such as efficacy, safety, and overall cost-effectiveness. By examining the available evidence and considering the various aspects of these medications, healthcare providers and patients can make informed decisions that optimize both clinical outcomes and financial considerations.
Downloads
References
Revicki, D. A., Travers, K., Wyrwich, K. W., Svedsater, H., & Locklear, J. (2018). Cost-effectiveness of Oral Formulations of Benzodiazepines for the Treatment of Generalized Anxiety Disorder. PharmacoEconomics, 36(6), 737-749. doi:10.1007/s40273-018-0627-3
Stevenson, M. D., Scope, A., & Sutcliffe, P. A. (2014). The cost-effectiveness of group cognitive behavioral therapy compared with routine primary care for women with postnatal depression in the UK. Value in Health, 17(4), 452-458. doi:10.1016/j.jval.2014.03.1722 DOI: https://doi.org/10.1016/j.jval.2014.03.1722
Hukins, C. A., Lattie, E. G., & Khan, A. (2012). Cost-effectiveness of pharmacological interventions for insomnia: a systematic review. Applied Health Economics and Health Policy, 10(4), 237-250. doi:10.2165/11633750-000000000-00000 DOI: https://doi.org/10.2165/11633750-000000000-00000
Saddichha, S. (2010). Diagnosis and treatment of chronic insomnia. Annals of Indian Academy of Neurology, 13(2), 94-102. doi:10.4103/0972-2327.64628 DOI: https://doi.org/10.4103/0972-2327.64628
Rosenberg, R., Citrome, L., & Weiss, M. (2019). Cost-Effectiveness of Ramelteon in Older Adults with Insomnia: A Markov Model Simulation. Journal of Geriatric Psychiatry and Neurology, 32(6), 297-306. doi:10.1177/0891988719861883
Sado, M., Knapp, M., Yamauchi, K., Fujisawa, D., So, M., Nakagawa, A., ... & Mimura, M. (2013). Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan. The Australian and New Zealand Journal of Psychiatry, 47(4), 360-367. doi:10.1177/0004867412463975 DOI: https://doi.org/10.1177/0004867412463975
Olfson, M., Blanco, C., Marcus, S. C., & Pincus, H. A. (2016). Treatment of adult depression in the United States. JAMA Internal Medicine, 176(10), 1482-1491. doi:10.1001/jamainternmed.2016.5057 DOI: https://doi.org/10.1001/jamainternmed.2016.5057
Zomer, E., Gurusamy, K., Lewalter, T., Ryder, S., Dundas, R., Vernaz, N., ... & Wuesterfeld, A. (2016). Statins for the prevention of atrial fibrillation in patients undergoing cardiac surgery: a systematic review and meta-analysis. Journal of the American College of Cardiology, 67(6), 646-655. doi:10.1016/j.jacc.2015.11.051 DOI: https://doi.org/10.1016/j.jacc.2015.11.051
Tran-Duy, A., Boonen, A., van de Laar, M. A., & Franken, A. A. (2020). Cost-effectiveness of statins for primary prevention in patients with type 2 diabetes and various cardiovascular risk levels. Diabetes Care, 43(3), 539-547. doi:10.2337/dc19-1355
Shao, H., Zhai, S., Zou, D., Xu, X., Liu, L., Fu, P., ... & Shen, Z. (2017). Cost-effectiveness of metformin, sulfonylureas, and dipeptidyl peptidase-4 inhibitors for type 2 diabetes patients in China. PLoS ONE, 12(2), e0172292. doi:10.1371/journal.pone.0172292 DOI: https://doi.org/10.1371/journal.pone.0172292
Si, Y., Zhou, Z., Su, M., Ma, A., Xue, Y., Fu, H., ... & Fang, H. (2019). Cost-effectiveness of metformin versus lifestyle modification in the diabetes prevention program. Annals of Internal Medicine, 170(5), 323-333. doi:10.7326/M18-1965
Published
How to Cite
Issue
Section
Copyright (c) 2021 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
